Ardevora Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-92,340
| Closed | -$35M | – | 122 |
|
|
2023
Q2 | $35M | Sell |
92,340
-13,014
| -12% | -$4.93M | 0.85% | 55 |
|
|
2023
Q1 | $50.5M | Sell |
105,354
-8,793
| -8% | -$4.21M | 0.91% | 54 |
|
|
2022
Q4 | $48M | Buy |
114,147
+9,918
| +10% | +$4.17M | 0.82% | 44 |
|
|
2022
Q3 | $43.5M | Sell |
104,229
-7,719
| -7% | -$3.22M | 0.78% | 64 |
|
|
2022
Q2 | $55.4M | Buy |
111,948
+4,200
| +4% | +$2.08M | 0.91% | 34 |
|
|
2022
Q1 | $60.7M | Buy |
107,748
+3,358
| +3% | +$1.89M | 0.79% | 73 |
|
|
2021
Q4 | $78.9M | Buy |
104,390
+900
| +0.9% | +$680K | 0.84% | 36 |
|
|
2021
Q3 | $77.2M | Sell |
103,490
-15,000
| -13% | -$11.2M | 0.98% | 7 |
|
|
2021
Q2 | $76.3M | Buy |
118,490
+25,933
| +28% | +$16.7M | 0.96% | 12 |
|
|
2021
Q1 | $52.9M | Sell |
92,557
-3,100
| -3% | -$1.77M | 0.79% | 76 |
|
|
2020
Q4 | $55.8M | Sell |
95,657
-10,100
| -10% | -$5.89M | 0.86% | 71 |
|
|
2020
Q3 | $54.5M | Buy |
105,757
+900
| +0.9% | +$464K | 1% | 24 |
|
|
2020
Q2 | $47.3M | Buy |
+104,857
| New | +$47.3M | 0.93% | 39 |
|